See every side of every news story

Published 2 days ago • loading... • Updated 2 days ago

Obesity Market Sales Potential Tightens as Novo and Lilly Enter New Era

Summary by WTVB

By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) – The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain with U.S. prices falling for GLP-1 treatments from Novo Nordisk and Eli Lilly and competition heating up in the cash-pay consumer market. The fast-changing landscape, which includes the expected entry of new drugs and gener…

3 Articles

3 Articles

Reposted by

WTVB

Obesity market sales potential tightens as Novo and Lilly enter new era

2 days ago·United Kingdom

Read Full Article

Pharmalittle: We're reading about obesity drug sales, India's biopharma research push, and more

Sanofi was criticized by a U.K. trade group for violating voluntary codes by making misleading and unsubstantiated claims about RSV vaccine

2 days ago·Boston, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right0Center3Last Updated1 day agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WTVB broke the news in 2 days ago on Monday, February 2, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics